Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 24 (5) , 1013-1021
Abstract
No abstract availableKeywords
Funding Information
- Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
- Sanofi-Genzyme
This publication has 44 references indexed in Scilit:
- How I treat refractory and early relapsed acute myeloid leukemiaBlood, 2015
- Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantationBlood, 2012
- A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)Blood, 2010
- Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology GroupBritish Journal of Haematology, 2009
- Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemiaHaematologica, 2007
- Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyBlood, 2006
- Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantationBlood, 2006
- Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic LeukemiaHematology-American Society Hematology Education Program, 2006
- Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)Leukemia, 2005
- Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-upBlood, 1992